Lead author Jeffrey Lazarus and co-author Jörn Schattenberg join Stephen Harrison, Louise Campbell, and Roger Green to discuss the groundbreaking paper “Advancing the Global Health Agenda for NAFLD.” This conversation focuses on what will happen now, why NAFLD is “the canary in the coal mine,” and how we can combine strengths in different parts of the world to make all of our programs more robust.
For Jeff Lazarus, “what’s next” includes a third, smaller Delphi study as well as a greater focus on Sustainable Development Goals (SDGs) around environment and possible diet. As it continues, Stephen Harrison discusses ways to persuade patients (and perhaps societies?) to change habits, practices, and beliefs radically to fight this disease. Louise Campbell returns to the issue of SDGs to discuss how advocates can leverage the increasing volume of liver cancer patients to represent larger related issues, which leads Jeff Lazarus to comment on how prevalent and costly liver cancer is today, compared to other cancers. In the end, Stephen Harrison recommends a two-item impact strategy: clear messages supported richly through large, high-impact multimedia campaigns.
Diagnostics, Doctor, Drugs, Patient Advocates, Patients, Policy and Perspectives
Tags:
